Ovid Therapeutics Inc. (OVID)
0.50
-0.03 (-5.66%)
At close: Mar 03, 2025, 3:59 PM
0.49
-0.50%
After-hours: Mar 03, 2025, 04:00 PM EST
Ovid Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Cash & Equivalents | 27.04M | 129M | 187.8M | 72.03M | 41.9M | 36.49M | 87.13M | 51.94M | 69.94M | 4.85M |
| Short-Term Investments | 78.79M | 84.13M | n/a | n/a | 34.84M | 5.01M | n/a | n/a | n/a | n/a |
| Long-Term Investments | 17.63M | 5.62M | 1.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.96M | 1.97M | 1.93M | 627.8K | 495.18K | 2.92M | 693.59K | 463.01K | 44.85K | 6.53K |
| Receivables | n/a | n/a | n/a | 141.76K | 1.13M | n/a | n/a | 7.37K | 58.64K | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 242.67K | n/a | n/a |
| Other Current Assets | 3.76M | 2.38M | 2.68M | 2.67M | 1.94M | 2.77M | 1.46M | 464.18K | 280.33K | 769.00 |
| Total Current Assets | 109.6M | 131.38M | 190.48M | 74.84M | 79.81M | 44.27M | 88.59M | 52.41M | 70.28M | 4.85M |
| Property-Plant & Equipment | 14.66M | 16.07M | 242.76K | 135.62K | 68.36K | 69.87K | 51.77K | 43.59K | 29.52K | 1.34K |
| Goodwill & Intangibles | 182.97K | 222.1K | 164.09K | 319K | 467K | 391.87K | 124.19K | 110.07K | 18.89K | 2.51K |
| Total Long-Term Assets | 34.43M | 23.89M | 4.07M | 1.08M | 1.03M | 3.38M | 869.55K | 616.68K | 93.26K | 10.38K |
| Total Assets | 144.03M | 155.27M | 194.54M | 75.93M | 80.84M | 47.65M | 89.46M | 53.03M | 70.38M | 4.86M |
| Account Payables | 3.7M | 1.95M | 7.13M | 5.45M | 3.26M | 3.76M | 2.03M | 857.17K | 670.54K | 79.14K |
| Deferred Revenue | n/a | n/a | n/a | 2.21M | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 1.25M | 533.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 6.53M | 4.5M | 7.67M | 14.4M | 7.28M | 5.09M | 4M | 2.88M | 1.64M | 40.81K |
| Total Current Liabilities | 11.47M | 6.99M | 14.8M | 22.06M | 10.53M | 8.84M | 6.02M | 3.73M | 2.31M | 119.95K |
| Long-Term Debt | 14.76M | 16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 30M | n/a | n/a | 61.2K | 286.56K | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 44.76M | 16M | n/a | 10.23M | 286.56K | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | 56.23M | 22.99M | 14.8M | 32.29M | 10.82M | 8.84M | 6.02M | 3.73M | 2.31M | 119.95K |
| Total Debt | 16M | 16.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 70.69K | 70.47K | 70.36K | 65.74K | 54.71K | 24.65K | 24.61K | 19.6K | 9.84K | 20K |
| Retained Earnings | -277.87M | -225.53M | -171.36M | -294.19M | -213.16M | -152.7M | -100.72M | -61.77M | -13.5M | -335.17K |
| Comprehensive Income | 702.00 | -42.19K | n/a | n/a | 2.47K | -1.83K | -50.91K | -20.19K | -3.9K | 0.00 |
| Shareholders Equity | 87.8M | 132.27M | 179.75M | 43.63M | 70.02M | 38.81M | 83.44M | 49.29M | 68.07M | 4.74M |
| Total Investments | 96.42M | 89.76M | 1.63M | n/a | 34.84M | 5.01M | n/a | n/a | n/a | n/a |